摘要 |
The invention provides compounds of formula (I), the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R<1>, R<2>, and R<7 >are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V1A antagonists.
|